Clinical Trials in San Diego

Showing 8981-9000 of 12,589 trials

Single-Treatment, Study of Percutaneous-Temperature Controlled-RF Electrocoagulation on Axilla Tissue

NCT03107065

This is a pilot, open-label, and single-center, single-treatment prospective evaluation of the electrocoagulation of axillary sweat gland tissue using the ThermiRF device to improve excessive sweating of the axilla(s). In this study, "Temporary Relief" is defined as improvement on the DLQI. Twenty male and female subjects between 18 and 50 years old will be enrolled. A total of five visits are planned for this study. A punch biopsy will be collected (prior to and post treatment and analyzed to determine the degree of impact to the tissue after the electrocoagulation treatment. Safety assessments will be collected using the Numerical Rating Scale (NRS) a 10-point scale, and adverse events reports (observed or reported). The total length of the study is approximately 4 months.

Sweating Increased Armpits

ThermiGen, LLC20 participantsStarted Dec 2016

San Diego, California, United States

COMPLETEDPhase 2< 1 mile

OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females

NCT02116361

This study will evaluate the safety and efficacy of onabotulinumtoxinA (BOTOX®) compared with placebo as treatment for major depressive disorder (MDD) in adult females.

Depressive Disorder, Major

Allergan258 participantsStarted Apr 2014

Little Rock, Alaska, United States • Bellflower, California, United States • Cerritos, California, United States +32 more locations

Single-Treatment, Study of Percutaneous-Temperature Controlled-RF Electrocoagulation on Axilla Tissue

OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females

Find Trials by Condition in San Diego

Safety and Efficacy Trial of Testosterone Undecanoate

Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II

Evaluation of the Ulthera System for the Treatment of the Decolletage

Safety, Antiviral Activity, and Pharmacokinetics of GSK2336805 With Peginterferon and Ribavirin in Chronic Hepatitis C Subjects

To Investigate the Safety, Tolerability and Pharmacodynamics of GSK2890457 in Healthy Volunteers and Subjects With Type 2 Diabetes

Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)

Phase III Study to Evaluate Efficacy and Safety of DSC127 in Diabetic Foot Ulcers

Open-Label Study in Diabetic Foot Ulcers (DFU), to Evaluate Safety of 0.03% DSC127 Topical Gel in Chronic Use

Efficacy of Panobinostat in Patients With Relapsed and Bortezomib-refractory Multiple Myeloma

Dose Escalation Study in Patients With Relapsed or Refractory DLBCL and MyD88 L265P Mutation

Safety and Immunogenicity of H1N1 Vaccines in Adults Aged 18 Years and Older

Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer

A Phase II Study of GSK1363089 (Formerly XL880) for Papillary Renal-Cell Carcinoma (PRC)

Randomized Clinical Trial of Bococizumab (PF-04950615; RN316) in Subjects Who Are Intolerant to Statins

HOPE Demonstration Field Experiment Multisite Evaluation

A Study of Vemurafenib in Participants With Metastatic Melanoma

A Study of Eltrombopag or Placebo in Combination With Azacitidine in Subjects With International Prognostic Scoring System (IPSS) Intermediate-1, Intermediate-2 or High-risk Myelodysplastic Syndromes (MDS)

Randomized Clinical Trial Comparing 4RIF vs. 9INH for LTBI Treatment-effectiveness